Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection 2022 (English)In: New England Journal of Medicine, ISSN 0028-4793, E-ISSN 1533-4406, Vol. 387, no 14, p. 1333-1336Article in journal (Refereed) Published

Place, publisher, year, edition, pages

Massachusetts Medical Society , 2022. Vol. 387, no 14, p. 1333-1336

Keywords [en]

coronavirus spike glycoprotein, immunoglobulin A, immunoglobulin G, SARS-CoV-2 vaccine, neutralizing antibody, spike protein, SARS-CoV-2, virus antibody, virus envelope protein, antibody detection, antibody response, controlled study, coronavirus disease 2019, correlation coefficient, cycle threshold value, follow up, health care personnel, human, immunity, infection risk, Letter, major clinical study, nonhuman, polymerase chain reaction, risk reduction, SARS-CoV-2 Omicron, screening, vaccinee, virus replication, immunology, prevention and control, virology, Antibodies, Neutralizing, Antibodies, Viral, COVID-19, Humans, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Viral Envelope Proteins

National Category

Immunology in the medical area

Identifiers

URN: urn:nbn:se:kth:diva-328150DOI: 10.1056/NEJMc2209651ISI: 000859732800001PubMedID: 36103621Scopus ID: 2-s2.0-85139573204OAI: oai:DiVA.org:kth-328150DiVA, id: diva2:1763562

Note

QC 20230607

Available from: 2023-06-07 Created: 2023-06-07 Last updated: 2023-06-07Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Nilsson, PeterHober, Sophia

Search in DiVA

By author/editor

Nilsson, PeterHober, Sophia

By organisation

Affinity ProteomicsProtein Technology

In the same journal

New England Journal of Medicine

On the subject

Immunology in the medical area

Search outside of DiVA

GoogleGoogle ScholarTotal: 147 hits